この画面を閉じる

ライセンス確認

Tet-On®発現誘導用組換えレンチウイルス

製品コード 0027VCT

rLV.EF1.Tet3G-9
ライセンス 以下のライセンスをご確認ください。
営利施設 営利施設の場合、ご購入前にライセンスを取得していただく必要があります。
該当するライセンス確認事項を確認のうえ、ご不明な点は弊社までお問い合わせください。

K45 Tet-Based Expression Products ライセンス

Use of the Tetracycline controllable expression systems (the "Tet Technology") is covered by a series of patents including U.S. Patent # 7541446, # 8383364, # 9181556 , European patents EP # 1200607, # 1954811, #2352833 and corresponding patent claims outside these regions which are proprietary to TET Systems GmbH & Co. KG. Academic research institutions are granted an automatic license with the purchase of this product to use the Tet Technology only for internal, academic research purposes, which license specifically excludes the right to sell, or otherwise transfer, the Tet Technology or its component parts to third parties. Notwithstanding the above, academic and not-for profit research institutions whose research using the Tet Technology is sponsored by for profit organizations, which shall receive ownership to any data and results stemming from the sponsored research, shall need a commercial license agreement from TET Systems in order to use the Tet Technology. In accepting this license, all users acknowledge that the Tet Technology is experimental in nature. TET Systems GmbH & Co. KG makes no warranties, express or implied or of any kind, and hereby disclaims any warranties, representations, or guarantees of any kind as to the Tet Technology, patents, or products. All others are invited to request a license from TET Systems GmbH & Co. KG prior to purchasing these reagents or using them for any purpose. Takara Bio USA, Inc. is required by its licensing agreement to submit a report of all purchasers of the Tet-controllable expression system to TET Systems.
For license information, please contact:
GSF/CEO,TET Systems GmbH & Co. KG, Im Neuenheimer Feld 582, 69120 Heidelberg, Germany
Tel: +49 6221 5880400,
Fax: +49 6221 5880404
eMail: info@tetsystems.com or use the electronic licensing request form via http://www.tetsystems.com/ip-licensing/licensing/for-profit-research

非営利目的の研究施設または法人のお客様へ
ご購入に際してライセンス確認書を提出することで研究目的での使用が可能となります。ご購入の際は、ライセンス確認書に必要事項をご記入の上、弊社販売店までお渡しください。ライセンス確認書が添付されていない場合、製品の出荷ができませんのでご注意ください。

営利目的の研究施設または法人のお客様へ
その使用目的にかかわらず、ご購入に先立ちTet Systems Holding Gmbh & Co KGからのライセンス(有償)の取得とライセンス確認書の提出が必要となります。ライセンスの取得については、下記Tet Systems Holding Gmbh & Co KGまでお問い合せください。 ご購入の際は、ライセンスを取得後、ライセンス確認書に必要事項をご記入の上、弊社販売店までお渡しください。ライセンス確認書が添付されていない場合、製品の出荷ができませんのでご注意ください。ライセンス取得後もご購入の際はその都度ライセンス確認書の提出が必要となります。

※Tet Systems社のポリシーの変更に伴い、2013年4月をもちまして、弊社によるお客様とTet Systems社とのライセンスに係る一切の仲介業務を終了いたしました。従いまして、下記のTet Systems社窓口にお客様から直接コンタクトを取り、交渉を行っていただく必要がございます。お客様にはご不便をおかけいたしますが、ご理解の程よろしくお願いいたします。

TET Systems GmbH & Co. KG, Im Neuenheimer Feld 582, 69120 Heidelberg, Germany
Tel: +49 6221 5880400,
Fax: +49 6221 5880404
eMail: info@tetsystems.com or use the electronic licensing request form via http://www.tetsystems.com/ip-licensing/licensing/for-profit-research

K95 Vectalys' technology ライセンス

Vectalys' highly concentrated and purified lentiviral vectors and its use are covered by U.S. Patent No. 13/0029379 and WO 2013/014537. The purchase price of this product includes limited, nontransferable rights to use this product solely for internal research purposes.
Academic and not-for-profit research institutions whose research using the Vectalys' Technology or the product obtained by the Vectalys' technology when sponsored by for profit organizations, which shall receive ownership to all data and results stemming from the sponsored research, shall need a commercial license agreement from Vectalys in order to use the Vectalys' Technology or the product obtained by the Vectalys' technology.
Please contact Vectalys for information on purchasing a license to use these products for commercial purposes: Parc Technologique du Canal, Bâtiment Canal Biotech II, 3, rue des satellites, 31400 Toulouse (France), TEL: +33(0)5 61 28 70 75, EMAIL: sandy.darrigan@vectalys.com.

K97 Lentikat™ system (SIN technology) ライセンス

Lentikat™ system (SIN technology) This product including the Lentiviral Technology (based upon the lentikat™ system) is sold pursuant to a licensing arrangement between Vectalys and Life Technologies Corporation. The purchase price of this product includes limited, nontransferable rights under U.S. Patent Nos. 5,994,136 and 6,165,782 and their foreign equivalents, excluding, however, any patents or patent equivalents filed with contracting states to the European Patent Convention or any extension states thereof, to use the product for internal research purposes directed to target validation and cellular screening only. Use of this technology for gene therapy applications or bioprocessing other than for non-human research use requires a license from GBP IP, LLC. The purchase of this product conveys to the buyer the non-transferable right to use the product in internal research directed to target validation and cellular screening conducted by the buyer (whether the buyer is an academic or for-profit entity), including such applications in laboratory animals. The buyer cannot sell or otherwise transfer (a) this product (b) its components or (c) materials made using this product or its components to a third party or otherwise use this product or its components or materials made using this product or its components for Commercial Purposes. The buyer may transfer information or materials made through the use of this product to a scientific collaborator, provided that such transfer is not for any Commercial Purpose, and that such collaborator agrees in writing (a) not to transfer such materials to any third party, and (b) to use such transferred materials and/or information solely for research as set forth herein and not for Commercial Purposes.

K98 cPPT Element ライセンス

cPPT Element

cPPT Element and its use are covered by one or more patents: FR9805197 and US 60/158387 and/or other pending foreign patent applications licensed to Vectalys. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The buyer cannot disclose information, sell or otherwise transfer this product, its components or materials made using this product or its components to a third party or otherwise use this product or its components or materials made using this product or its components for any commercial purposes. If the buyer is not willing to accept the limitations of this limited use statement, Vectalys is willing to accept return of the product with a full refund. For information on purchasing a license to the DNA-Flap technology for purposes other than research, contact the Transfer of Technology Office, Institut Pasteur, 28 rue du Docteur Roux, 75 724 Paris Cedex 15 (www.pasteur.fr).

K99 Nuclear Programming Factors and iPSCs ライセンス

Nuclear Programming Factors and iPSCs

Use of iPS is covered by a series of patents including Japanese Patent No. 4,183,742 and its corresponding foreign patent applications and/or patents. END USER shall not use the LICENSED PRODUCTS, iPSCs generated by use of the LICENSED PRODUCT or derivatives thereof for uses other than for END USER’s internal research use in the END USER FIELD OF USE. END USER FIELD OF USE means noncommercial internal research use only. END USER FIELD OF USE excludes research involving application and use of LICENSED PRODUCTS, iPSCs generated by use of the LICENSED PRODUCT or derivatives thereof for human/animal therapeutic, diagnostic and/or prophylactic purposes. END USER FIELD OF USE also excludes research for Commercial Purpose. “Commercial Purpose” shall mean any activity by an END USER including at least one of following activities: (i) use of the LICENSED PRODUCTS or components of vectors, or iPSCs generated by use of the LICENSED PRODUCT or derivatives thereof for development, or manufacture of related products including but not limited to culture medium and equipment, (ii) use of the LICENSED PRODUCTS or components of vectors, or iPSCs generated by use of the LICENSED PRODUCT or derivatives thereof to provide a service, information or data to a third party, and (iii) use of the LICENSED PRODUCTS or components of vectors, or iPSCs generated by use of the LICENSED PRODUCT or derivatives thereof for screening compounds, antibodies, proteins, peptides and the other as potential pharmaceutical compounds. For the avoidance of doubts, any type of joint development between non-commercial organization and commercial organization is considered as an internal use for “Commercial Purposes.” If END USER wishes to use the LICENSED PRODUCTS, or iPSCs generated by use of the LICENSED PRODUCT or derivatives thereof in the END USER FIELD OF USE for Commercial Purpose, END USER notifies: iPS Academia Japan, Inc. 448-5-201 Kajii-cho, Kamigyo-ku, Kyoto 602-0841, Japan, ATTN: Vice President, License for such use, and then shall negotiate for a license from iPS Academia, Japan Inc. to use the LICENSED PRODUCTS, iPSCs generated by use of the LICENSED PRODUCT or derivatives with iPS Academia Japan, Inc. and agree to take a required license. END USER shall not transfer, sell or supply any LICENSED PRODUCTS, or iPSCs generated by use of the LICENSED PRODUCT or derivatives thereof to any third parties. END USER shall not use the LICENSED PRODUCTS, or iPSCs generated by use of the LICENSED PRODUCT or derivatives thereof, for application and use for human/animal therapeutic, diagnostic and/or prophylactic purposes. No other right, express or implied, is conveyed by the sale of the LICENSED PRODUCTS or the rendering of the LICENSED SERVICES.

ライセンス確認書(同意書)

ライセンス対象製品は、ご購入に際してライセンス確認書が必要になります。また、営利施設の場合、ご購入前にライセンス契約を結ぶ必要のある製品がございます。
ライセンス確認書および使用施設名ユーザー名確認書をご提出いただく前に、添付の「登録やライセンスに関する情報」を必ずご確認ください。
製品は研究用試薬として販売しております。工業用および臨床用には使用できませんのでご了承ください。また、ご購入者以外の方への譲渡、再販売はできませんので、ご注意ください。
※ご記入後、弊社製品取扱い販売店にお渡しください。ご注文の際に、確認書が添付されていない場合は、製品の出荷ができませんのでご注意ください。

license.pdf

お問い合わせ先

タカラバイオ(株) 営業企画部 担当
TEL:077-565-6972

この画面を閉じる